AJG
Arthur J. Gallagher & Co.
AJG's outlook is improving, though it still trails on the overall score.
BAC
Bank of America Corporation
BAC has the edge over AJG overall, supported by stronger fundamentals and stronger valuation.
AJG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
AJG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AJG.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
AJG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $277 | — |
| Cheap | 30x | $195 | -30% |
| Fair | 38x | $250 | -9.7% |
| Current | 42x | $277 | — |
| Expensive | 51x | $332 | +20% |
Historical ranges are pointers, not guarantees.
AJG's PE is in its expensive range at 42x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its cheap range.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over AJG in the historical PE scenario, which offers more potential upside but is not a forecast.
AJG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for AJG, with profitability improving.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
AJG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.41 | +120% |
| Q3 2026 | $6.54 | +4.5% |
| Q2 2026 | $6.03 | -8.8% |
| Q1 2026 | $6.18 | -4.6% |
| Q4 2025 | $5.74 | -12% |
| Q3 2025 | $6.26 | +20% |
| Q2 2025 | $6.61 | +29% |
| Q1 2025 | $6.48 | +32% |
| Q4 2024 | $6.50 | +47% |
AJG earned $6.54 per share over the past year, up 4.5% from the year before.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over AJG on earnings, with more consistent year-over-year improvement.
AJG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4B | +18% |
| Q2 2026 | $4B | +24% |
| Q1 2026 | $4.8B | +28% |
| Q4 2025 | $3.6B | +34% |
| Q3 2025 | $3.4B | +20% |
| Q2 2025 | $3.2B | +16% |
| Q1 2025 | $3.7B | +14% |
| Q4 2024 | $2.7B | +12% |
AJG has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +2.6 points |
| Q2 2026 | 10% | -4.3 points |
| Q1 2026 | 22% | -1.5 points |
| Q4 2025 | 5% | -7.3 points |
| Q3 2025 | 10% | -4.1 points |
| Q2 2025 | 15% | +1.5 points |
| Q1 2025 | 23% | -0.3 points |
| Q4 2024 | 12% | +16 points |
AJG's operating margin was 13% last quarter, up 2.6 points from the same quarter a year ago.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over AJG on profitability, with a higher operating margin.
AJG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +87% |
| Q2 2026 | -$41M | +$424.5M |
| Q1 2026 | $921M | +9.2% |
| Q4 2025 | $713.4M | +2.5% |
| Q3 2025 | $693.5M | -23% |
| Q2 2025 | -$465.5M | -631% |
| Q1 2025 | $843.6M | +11% |
| Q4 2024 | $695.7M | +7.4% |
AJG has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
AJG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | +100K shares |
| 3 years | +19% | +41M shares |
| 5 years | +24% | +49.7M shares |
| Available history | +38% | +70.7M shares |
AJG has 257M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100M |
| Q2 2026 | $170M |
| Q1 2026 | $310M |
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over AJG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
AJG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 3.6x | Elevated |
| Q1 2026 | 3.5x | Elevated |
| Q4 2025 | 3.8x | Elevated |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -1.3x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
AJG has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
AJG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.3 | Neutral |
| Stochastic | 85.8 | Overbought |
AJG's weekly RSI is 63 (neutral) and its Stochastic is 86 (overbought).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
AJG PE vs Financial Services Sector
| Metric | AJG | Sector median | Relative |
|---|---|---|---|
| PE | 42x | 13x | 226% above |
| PE % | 66 | 63 | 3 pts above |
AJG is trading at 42x earnings, a 226% premium to the Financial Services sector's median of 13x.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over AJG on valuation relative to its sector.
AJG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $256.0 | 8.3% above |
| 20 week MA | $253.9 | 9.2% above |
| 50 week MA | $237.6 | 17% above |
| 100 week MA | $271.8 | 2% above |
| 200 week MA | $256.1 | 8.3% above |
AJG has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
AJG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $94.8 | $123.4 | +30% |
| 2021 | $123.4 | $166.5 | +35% |
| 2022 | $166.5 | $188.4 | +13% |
| 2023 | $188.4 | $224.9 | +19% |
| 2024 | $224.9 | $286.5 | +27% |
| 2025 | $286.5 | $261.5 | -8.7% |
| 2026 YTD | $261.5 | $277.3 | +6% |
AJG has the edge over BAC on returns for 2026, with the stronger performance.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.